KAISER PETER (Chief Development Officer) sold 1.1% of their position (2.97K shares) of OCULAR THERAPEUTIX, INC on the open market
Open‑market sale worth $24.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/28/2026ACC: 0001104659-26-067483
Officer· Chief Development Officer
Since Feb 2026
-2.97K
Net shares
Net seller
$24.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.97K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.97K
Price / share
$8.20
Trade value
$24.33K
% of position
1.1%
5/26/2026
269.11K→266.14K
Total
Net shares
−2.97K
Net value
-$24.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2026 | S · Sale | −2.97K | $8.20 | $24.33K | 1.1% | 269.11K | 266.14K |
| Total | −2.97K | -$24.33K | ||||||
Derivative Transactions0
No derivative transactions reported